Ishara Investments LP
Long book
$99.0M
Q1 2026
Positions
36
Top-10 weight
51%
concentration
Last quarter
+21.4%
SPY +14.8%
Turnover
65%
of book per quarter
Strategy in plain words
auto-generated from filingsIshara Investments LP is a concentrated fundamental stock-picker, specialised in healthcare (100% of the long book), running a $99.0M US long book across 36 positions.
The portfolio is concentrated: the top 10 names carry 51% of the portfolio. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: PRAXIS PRECISION MEDICINES I, AXSOME THERAPEUTICS INC, XERIS BIOPHARMA HOLDINGS INC, KALVISTA PHARMACEUTICALS INC, AMICUS THERAPEUTICS INC.
We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q4 2025
+0.8%
Q1 2026
+21.4%
Sector allocation
Healthcare 88%
Other 12%
Long book by quarter
What does Ishara Investments own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 22.6K | $7.3M | 7.3% | -43.6% |
| AXSM AXSOME THERAPEUTICS INC | Healthcare | 41.0K | $6.9M | 7.0% | New |
| XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 1.0M | $5.9M | 6.0% | +28.1% |
| 4XC1 KALVISTA PHARMACEUTICALS INC | — | 276.8K | $5.6M | 5.6% | New |
| AM6 AMICUS THERAPEUTICS INC | — | 369.0K | $5.3M | 5.4% | +2.5% |
| BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 82.0K | $4.6M | 4.7% | -18.0% |
| VSTM VERASTEM INC | Healthcare | 820.0K | $4.3M | 4.4% | +203.7% |
| RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 174.3K | $3.7M | 3.7% | +248.5% |
| ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 55.4K | $3.5M | 3.5% | New |
| PCVX VAXCYTE INC | Healthcare | 57.4K | $3.3M | 3.4% | +14.8% |
| VERA VERA THERAPEUTICS INC | Healthcare | 82.0K | $3.3M | 3.3% | New |
| TVTX TRAVERE THERAPEUTICS INC | Healthcare | 110.7K | $3.3M | 3.3% | New |
| MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 174.3K | $3.2M | 3.3% | New |
| ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 1.2M | $2.9M | 2.9% | -6.8% |
| SRRK SCHOLAR ROCK HOLDING CORP | Healthcare | 57.4K | $2.8M | 2.8% | New |
| ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 123.0K | $2.7M | 2.8% | -23.1% |
| ARDX ARDELYX INC | Healthcare | 451.0K | $2.7M | 2.7% | New |
| MLYS MINERALYS THERAPEUTICS INC | Healthcare | 82.0K | $2.2M | 2.2% | New |
| CPRX CATALYST PHARMACEUTICALS INC | Healthcare | 82.0K | $2.0M | 2.1% | New |
| SION SIONNA THERAPEUTICS INC | Healthcare | 49.2K | $2.0M | 2.0% | New |
| CTNM CONTINEUM THERAPEUTICS INC-A | Healthcare | 142.0K | $1.9M | 1.9% | New |
| ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 5.1K | $1.7M | 1.7% | New |
| LGND LIGAND PHARMACEUTICALS | Healthcare | 8.2K | $1.6M | 1.7% | New |
| EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 49.2K | $1.5M | 1.6% | -15.2% |
| IMTX IMMATICS NV | Healthcare | 153.8K | $1.5M | 1.5% | +92.2% |
| LXRX LEXICON PHARMACEUTICALS INC | Healthcare | 902.0K | $1.4M | 1.4% | +2.5% |
| BEAM BEAM THERAPEUTICS INC | Healthcare | 57.4K | $1.4M | 1.4% | +14.8% |
| ORIC ORIC PHARMACEUTICALS INC | Healthcare | 102.5K | $1.3M | 1.3% | -35.9% |
| NAMS NEWAMSTERDAM PHARMA CO NV | Healthcare | 36.9K | $1.2M | 1.2% | +23.0% |
| ANNX ANNEXON INC | Healthcare | 174.3K | $965K | 1.0% | -76.8% |
| IDYA IDEAYA BIOSCIENCES INC | Healthcare | 24.6K | $820K | 0.8% | New |
| PTCT PTC THERAPEUTICS INC | Healthcare | 10.3K | $698K | 0.7% | -71.5% |
| GOSS GOSSAMER BIO INC | Healthcare | 820.0K | $269K | 0.3% | New |